Low yield of genetic testing for known vascular connective tissue disorders in patients with fibromuscular dysplasia

Vascular Medicine (United Kingdom)

Volumn 17, Issue 6, 2012, Pages 371-378

  Poloskey, Stacey L ^a   Kim, Esther S H ^a   Sanghani, Ruchi ^a   Al Quthami, Adeeb H ^b   Arscott, Patricia ^c   Moran, Rocio ^d   Rigelsky, Christina M ^d   Gornik, Heather L ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

fibromuscular dysplasia; genetics; peripheral vascular diseases

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 3; COLLAGEN TYPE 3A1; FIBRILLIN I; SMAD3 PROTEIN; SMOOTH MUSCLE ALPHA ACTIN 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; AORTA; AORTA ANEURYSM; AORTA DISSECTION; ARTERY DISSECTION; BRAIN ARTERY; CEREBROVASCULAR ACCIDENT; CONNECTIVE TISSUE DISEASE; CORONARY ARTERY; FAMILY HISTORY; FEMALE; FIBROMUSCULAR DYSPLASIA; GENETIC COUNSELING; GENETIC SCREENING; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; LEG ARTERY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MESENTERIC ARTERY; PHENOTYPE; PRIORITY JOURNAL; RENAL ARTERY; REVIEW; SUDDEN DEATH; VASCULAR CONNECTIVE TISSUE DISORDER; VERTEBRAL ARTERY;

ADULT; ANEURYSM, DISSECTING; AORTIC ANEURYSM; CONNECTIVE TISSUE; CONNECTIVE TISSUE DISEASES; FEMALE; FIBROMUSCULAR DYSPLASIA; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK;

EID: 84870214399     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X12459650     Document Type: Review

References (48)

1. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004 ; 350: 1862-1871
2. Harrison EG, McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc. 1971 ; 46: 161-167
3. Stanley JC, Gewertz BL, Bove EL, et al. Arterial fibrodysplasia. Histopathologic character and current etiologic concepts. Arch Surg. 1975 ; 110: 561-566
4. McCormack LJ, Poutasse EF, Meaney TF, et al. A pathologic-arteriographic correlation of renal arterial disease. Am Heart J. 1966 ; 72: 188-198
5. Harrison EG, Hunt JC, Bernatz PE. Morphology of fibromuscular dysplasia of the renal artery in renovascular hypertension. Am J Med. 1967 ; 43: 97-112
6. Olin JW, Sealove BA. Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg. 2011 ; 53: 826-836.e1
7. Sang CN, Whelton PK, Hamper , et al. Etiologic factors in renovascular fibromuscular dysplasia. A case-control study. Hypertension. 1989 ; 14: 472-479 (Pubitemid 19270511)
8. Halpern MM, Sanford HS, Viamonte M. Renal-artery abnormalities in three hypertensive sisters. Probable familial fibromuscular hyperplasia. JAMA. 1965 ; 194: 512-513
9. Hansen J, Holten C, Thorborg JV. Hypertension in two sisters caused by so-called fibromuscular hyperplasia of the renal arteries. Acta Med Scand. 1965 ; 178: 461-474
10. Ouchi Y, Tagawa H, Yamakado M, et al. Clinical significance of cerebral aneurysm in renovascular hypertension due to fibromuscular dysplasia: Two cases in siblings. Angiology. 1989 ; 40: 581-588 (Pubitemid 19138328)
11. Bigazzi R, Bianchi S, Quilici N, et al. Bilateral fibromuscular dysplasia in identical twins. Am J Kidney Dis. 1998 ; 32: E4
12. Dominguez FE, Tate LG, Robinson MJ. Familial fibromuscular dysplasia presenting as sudden death. Am J Cardiovasc Pathol. 1988 ; 2: 269-272 (Pubitemid 19056929)
13. Major P, Genest J, Cartier P, et al. Hereditary fibromuscular dysplasia with renovascular hypertension. Ann Intern Med. 1977 ; 86: 583 (Pubitemid 8091112)
14. Rushton AR. The genetics of fibromuscular dysplasia. Arch Intern Med. 1980 ; 140: 233-236 (Pubitemid 10147667)
15. Gladstien K, Rushton AR, Kidd KK. Penetrance estimates and recurrence risks for fibromuscular dysplasia. Clin Genet. 1980 ; 17: 115-116 (Pubitemid 10155002)
16. Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke. 1982 ; 13: 46-52 (Pubitemid 12219048)
17. Grimbert P, Fiquer-Kempf B, Coudol P, et al. Genetic study of renal artery fibromuscular dysplasia. Arch Mal Coeur Vaiss. 1998 ; 91: 1069-1071 (Pubitemid 28385285)
18. Perdu J, Boutouyrie P, Bourgain C, et al. Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens. 2007 ; 21: 393-400 (Pubitemid 46646173)
19. Pannier-Moreau I, Grimbert P, Fiquet-Kempf B, et al. Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens. 1997 ; 15: 1797-1801 (Pubitemid 28029684)
20. Schievink WI, Bjornsson J, Parisi JE, et al. Arterial fibromuscular dysplasia associated with severe alpha 1-antitrypsin deficiency. Mayo Clin Proc. 1994 ; 69: 1040-1043 (Pubitemid 24346985)
21. Schievink WI, Puumala MR, Meyer FB, et al. Giant intracranial aneurysm and fibromuscular dysplasia in an adolescent with alpha 1-antitrypsin deficiency. J Neurosurg. 1996 ; 85: 503-506 (Pubitemid 26278036)
22. Schievink WI, Meyer FB, Parisi JE, et al. Fibromuscular dysplasia of the internal carotid artery associated with alpha1-antitrypsin deficiency. Neurosurgery. 1998 ; 43: 229-233
23. Bofinger A, Hawley C, Fisher P, et al. Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. J Hum Hypertens. 2000 ; 14: 91-94 (Pubitemid 30110440)
24. Bofinger A, Hawley C, Fisher P, et al. Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia. J Hum Hypertens. 2001 ; 15: 185-190 (Pubitemid 32181484)
25. Sanchez Torres G, Contreras R. Fibromuscular dysplasia: A genetic entity related to Ehlers-Danlos syndrome. Arch Inst Cardiol Mex. 1974 ; 44: 571-581
26. Schievink WI, Limburg M. Angiographic abnormalities mimicking fibromuscular dysplasia in a patient with Ehlers-Danlos syndrome, type IV. Neurosurgery. 1989 ; 25: 482-483
27. Schievink WI, Bjornsson J, Piepgras DG. Coexistence of fibromuscular dysplasia and cystic medial necrosis in a patient with Marfan's syndrome and bilateral carotid artery dissections. Stroke. 1994 ; 25: 2492-2496 (Pubitemid 24359325)
28. Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005 ; 37: 275-281 (Pubitemid 41716254)
29. Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006 ; 355: 788-798 (Pubitemid 44285584)
30. Van de Laar IM, Oldenburg RA, Pals G, et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet. 2011 ; 43: 121-126
31. Van de Laar IM, van der Linde D, Oei EH, et al. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet. 2012 ; 49: 47-57
32. Regalado ES, Guo DC, Villamizar C, et al. Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circ Res. 2011 ; 109: 680-686
33. Guo DC, Pannu H, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007 ; 39: 1488-1493 (Pubitemid 350191352)
34. Renard M, Callewaert B, Baetens M, et al. Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAAD. Int J Cardiol. 2011 ;:
35. Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009 ; 84: 617-627
36. Olin JW, Froehlich J, Gu X, et al. The United States registry for fibromuscular dysplasia: Results in the first 447 patients. Circulation. 2012 ; 125: 3182-3190
37. McDonnell NB, Yang J, Chen W, et al American Society of Human Genetics Annual Meeting. LA: New Orleans ; 2006:
38. Marks SD, Gullett AM, Brennan E, et al. Renal FMD may not confer a familial hypertensive risk nor is it caused by ACTA2 mutations. Pediatr Nephrol ; 2011 ; 2011. 1857.
39. Pasche B, Luo Y, Rao PH, et al. Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res. 1998 ; 58: 2727-2732 (Pubitemid 28311899)
40. Vellucci VF, Reiss M. Cloning and genomic organization of the human transforming growth factor-beta type I receptor gene. Genomics. 1997 ; 46: 278-283 (Pubitemid 28013424)
41. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors. 1993 ; 8: 1-9 (Pubitemid 23093206)
42. Stheneur C, Collod-Beroud G, Faivre L, et al. Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders. Hum Mutat. 2008 ; 29: E284-295
43. Blondel B, Launay F, Jacopin S, et al. Siblings with vascular involvement associated with hereditary multiples exostosis. J Pediatr Orthop B. 2011 ;:
44. Pavic P, Vergles D, Sarlija M, et al. Pseudoaneurysm of the popliteal artery in a patient with multiple hereditary exostoses. Ann Vasc Surg. 2011 ; 25: 268.e1-268.e2
45. Grange DK, Balfour IC, Chen SC, et al. Familial syndrome of progressive arterial occlusive disease consistent with fibromuscular dysplasia, hypertension, congenital cardiac defects, bone fragility, brachysyndactyly, and learning disabilities. Am J Med Genet. 1998 ; 75: 469-480
46. Wessels MW, Catsman-Berrevoets CE, Mancini GM, et al. Three new families with arterial tortuosity syndrome. Am J Med Genet A. 2004 ; 131: 134-143 (Pubitemid 39578344)
47. Allen VM, Horne SG, Penney LS, et al. Successful outcome in pregnancy with arterial tortuosity syndrome. Obstet Gynecol. 2009 ; 114: 494-498
48. Coucke PJ, Willaert A, Wessels MW, et al. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet. 2006 ; 38: 452-457